Innovent Biologics, Inc.
IVBXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7,508,185 | $10,052,095 | $1,016,165 | $1,359,408 |
| Short-Term Investments | $375,555 | $867,534 | $7,248,429 | $6,581,485 |
| Receivables | $1,566,930 | $1,005,891 | $911,790 | $1,181,666 |
| Inventory | $822,167 | $968,088 | $1,428,882 | $1,347,240 |
| Other Curr. Assets | $0 | $484,377 | $0 | $6,635 |
| Total Curr. Assets | $10,272,837 | $13,427,985 | $11,506,708 | $11,550,849 |
| Property Plant & Equip (Net) | $5,647,242 | $4,656,384 | $4,060,719 | $3,375,757 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1,282,603 | $27,788 | $1,198,163 | $772,194 |
| Long-Term Investments | $3,900,896 | $794,089 | $630,197 | -$6,164,230 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $499,024 | $1,721,114 | $193,058 | $6,709,143 |
| Total NC Assets | $11,329,765 | $7,199,375 | $6,082,137 | $4,692,864 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $21,602,602 | $20,627,360 | $17,588,845 | $16,243,713 |
| Liabilities | – | – | – | – |
| Payables | $357,677 | $372,549 | $325,622 | $195,050 |
| Short-Term Debt | $413,929 | $1,220,330 | $914,392 | $387,273 |
| Tax Payable | $0 | $194,049 | $61,015 | $92,776 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,597,263 | $2,689,888 | $2,198,169 | $2,374,948 |
| Total Curr. Liab. | $4,368,869 | $4,476,816 | $3,499,198 | $3,050,047 |
| LT Debt | $2,417,114 | $2,400,199 | $2,314,116 | $2,109,653 |
| Deferred Rev, NC | $0 | $960,051 | $883,277 | $753,274 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1,698,890 | $262,713 | $162,305 | $342 |
| Total NC Liab. | $4,116,004 | $3,622,963 | $3,359,698 | $2,863,269 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $13,589 | $98,597 | $125,075 | $108,665 |
| Total Liabilities | $8,484,873 | $8,099,779 | $6,858,896 | $5,913,316 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $113 | $112 | $105 | $101 |
| Retained Earnings | -$15,906,368 | -$15,767,568 | -$14,739,655 | -$12,560,385 |
| AOCI | $1,301,360 | $970,541 | $763,861 | $397,023 |
| Other Equity | $27,722,624 | $27,324,496 | $24,705,638 | $22,493,658 |
| Total Equity | $13,117,729 | $12,527,581 | $10,729,949 | $10,330,397 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $21,602,602 | $20,627,360 | $17,588,845 | $16,243,713 |
| Net Debt | -$4,677,142 | -$6,431,566 | $2,212,343 | $1,137,518 |